KOSDAQ - Delayed Quote KRW

Hugel, Inc. (145020.KQ)

335,000.00

+25,500.00

+(8.24%)

As of 12:43:21 PM GMT+9. Market Open.

Hugel achieves record net sales, profit, net income in 2024

Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, posted record-breaking earnings in 2024 with KRW373.0 billion in net sales and KRW166.3 billion in operating profit, respectively up 16.7% and 41.2% year-over-year. Net income increased 45.8% on-year to KRW142.4 billion.

PR Newswire last month

145020.KQ
+8.24%
145020.KS
Hugel wins UAE approval for botulinum toxin Botulax

Hugel Inc., a leading global medical aesthetics company chaired by Suk Cha, said on Wednesday it received approval for its botulinum toxin Botulax with aesthetic and therapeutic applications from the United Arab Emirates (UAE) on January 20, achieving a significant milestone for the company's global expansion.

PR Newswire 2 months ago

145020.KQ
+8.24%
145020.KS
Hugel vows to become global leader at J.P. Morgan Healthcare Conference

Hugel Inc., a leading global medical aesthetics company, announced its key achievements in 2024 and presented the mid- to long-term growth strategy throughout 2028 at the J.P. Morgan Healthcare Conference in San Francisco, the US, on Thursday.

PR Newswire 2 months ago

145020.KQ
+8.24%
145020.KS
Hugel and Medica join forces to boost botulinum toxin sales in Middle East, North Africa

Hugel Inc., a leading global medical aesthetics company, said on Friday it will spur expansion in the botulinum toxin market of the Middle East and North Africa (MENA) via a strategic partnership with Dubai-headquartered aesthetic and medical distribution partner Medica Group.

PR Newswire 4 months ago

145020.KQ
+8.24%
145020.KS
Hugel hits record net sales, operating profit in Q3

Hugel, a leading global medical aesthetics company, announced the consolidated financial statement for the third quarter of 2024 on November 6, reporting KRW105.1 billion in net sales, KRW53.4 billion in operating profit and KR42 billion in net income.

PR Newswire 4 months ago

145020.KQ
+8.24%
145020.KS
Hugel's skincare brand WELLAGE joins K-beauty festival in New York

Hugel Inc., a leading global medical aesthetics company, said on Tuesday that WELLAGE, its clinical derma cosmetics brand for skin wellness, joined the festival K-beauty Boost in NYC 2024 at the Korean Cultural Center New York on November 1 to promote its expertise in skincare.

PR Newswire 5 months ago

145020.KQ
+8.24%
145020.KS
ITC issues final ruling in favor of Hugel (no violation of Section 337)

Hugel Inc., a leading global medical aesthetics company, announced that the Administrative Law Judge (ALJ) for its U.S. International Trade Commission (ITC) investigation issued the final determination on October 10 (local time) that "there is no violation of Section 337" based on Medytox's allegation of unfair practices concerning the importation of certain botulinum neurotoxin (BTX) products into the United States (Inv. No. 337-TA-1313).

PR Newswire 5 months ago

145020.KQ
+8.24%
145020.KS
Hugel hit Record High Quarterly Revenue and Operating Profit

Hugel, a global total medical aesthetics company, announced consolidated financial statements for the second quarter of 2024 on August 7th, reporting revenue of KRW95.4billion, operating profit of KRW42.4billion, and net income of KRW37billion.

PR Newswire 7 months ago

145020.KQ
+8.24%
145020.KS
Hugel Inc. and BENEV Company Inc. Announce Strategic Partnership in the U.S. Market

Hugel Inc., a global total medical aesthetics company, will officially enter the U.S. market through a strategic partnership with BENEV Company Inc. based in California, U.S.A.

PR Newswire 9 months ago

145020.KQ
+8.24%
145020.KS
ITC final initial determination Ruled in favor of Hugel (no violation of Section 337)

Hugel Inc, a global total medical aesthetics company, announced that the Administrative Law Judge (ALJ) for its U.S. International Trade Commission(ITC) investigation issued an initial determination on June 10th (local time) finding that "there is no violation of Section 337" based on Medytox's allegation of unfair practices concerning the importation of certain botulinum neurotoxin(BTX) products into the United States (Inv. No. 337-TA-1313).

PR Newswire 9 months ago

145020.KQ
+8.24%
145020.KS
Hugel Achieves Record High Revenue for the First Quarter

Hugel, a global total medical aesthetics company, announced its 1Q24 consolidated financial results on the 9th, reporting revenue of KRW 74.3 billion, operating profit of KRW 24 billion, and net income of KRW 22.7 billion.

PR Newswire 10 months ago

145020.KQ
+8.24%
145020.KS

Performance Overview

Return	145020.KQ	KOSPI Composite Index (^KS11)
YTD	+19.43%	+0.74%
1-Year	+72.41%	-10.64%
3-Year	+178.01%	-10.49%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hugel, Inc. (145020.KQ)

Hugel achieves record net sales, profit, net income in 2024

Hugel wins UAE approval for botulinum toxin Botulax

Hugel vows to become global leader at J.P. Morgan Healthcare Conference

Hugel and Medica join forces to boost botulinum toxin sales in Middle East, North Africa

Hugel hits record net sales, operating profit in Q3

Hugel's skincare brand WELLAGE joins K-beauty festival in New York

ITC issues final ruling in favor of Hugel (no violation of Section 337)

Hugel hit Record High Quarterly Revenue and Operating Profit

Hugel Inc. and BENEV Company Inc. Announce Strategic Partnership in the U.S. Market

ITC final initial determination Ruled in favor of Hugel (no violation of Section 337)

Hugel Achieves Record High Revenue for the First Quarter

Performance Overview